期刊文献+

68Ga标记TMTP1探针在肝癌肿瘤模型中的microPET/CT显像研究

Study on microPET/CT imaging of 68Ga-labeled TMTP1 probe in HCC tumor model
下载PDF
导出
摘要 目的研究68Ga[Ga]-NOTA-PEG2-TMTP1对SMMC-7721肝癌荷瘤小鼠模型的诊断效果.方法氨肽酶P2在一些肿瘤(如肝癌、肺癌、乳腺癌等)中有高表达.TMTP1可以特异性地靶向氨肽酶P2,本研究利用68Ga标记NOTA-PEG2-TMTP1合成68Ga[Ga]-NOTA-PEG2-TMTP1,然后对SMMC-7721肝癌荷瘤小鼠进行microPET/CT显像研究,研究其对肿瘤的诊断效果.结果68Ga[Ga]-NOTA-PEG2-TMTP1的放射性标记产率为(87.16±1.23)%,放化纯度大于99.0%.实验证明PEG修饰后的TMTP1,具有更好的肿瘤靶向性,肿瘤肌肉比可以高达5.66.结论对于肝癌的诊断来说,68Ga[Ga]-NOTA-PEG2-TMTP1可能是更好的PET探针,具有进一步临床转化的前景. Objective To investigate the diagnostic effect of 68Ga[Ga]-NOTA-PEG2-TMTP1 on a mouse model of SMMC-7721 hepatocellular carcinoma in nude mice.Methods Aminopeptidase P2 was highly expressed in some tumors(e.g.,liver,lung,breast cancer,etc.).TMTP1 could specifically target aminopeptidase P2.In this study,68Ga[Ga]-NOTA-PEG2-TMTP1 was synthesized using 68Ga-labeled NOTA-PEG2-TMTP1,then SMMC-7721 hepatocellular carcinoma tumor-bearing nude mice for microPET/CT imaging study to investigate its diagnostic effect on tumors.Results The radiolabelling yield of 68Ga[Ga]-NOTA-PEG2-TMTP1 was(87.16±1.23)%,and the radiochemical purity was greater than 99.0%.It was demonstrated that TMTP1,after PEG modification,had better tumor targeting,with tumor muscle ratio up to 5.66.Conclusion For the diagnosis of hepatocellular carcinoma,68Ga[Ga]-NOTA-PEG2-TMTP1 may be a better PET probe with the prospect of further clinical translation.
作者 李业森 LI Yesen(Department of Nuclear Medicine,the First Affiliated Hospital of Xiamen University,Xiamen,Fujian 361003,China)
出处 《福建医药杂志》 CAS 2022年第5期122-124,共3页 Fujian Medical Journal
基金 福建省自然科学基金资助项目(2020J011224)。
关键词 PET 肝癌 68Ga[Ga]-NOTA-PEG2-TMTP1 68Ga标记 PET hepatocelluar carcinoma 68Ga[6a]-NDTA-PEG2-TMTP1 68Ga labelling
  • 相关文献

参考文献2

二级参考文献17

  • 1Yang JD, Nakamura I,Roberts LR. The tumor microenvironmentin hepatocellular carcinoma : current status and therapeutic targets[J] . Semin Cancer Biol, 2011,21 ( 1) : 35-43.
  • 2He J, Gu D, Wu X,et al. Major causes of death among men andwomen in China[ J]. N Engl J Med, 2005, 353( 11): 1124-1134.
  • 3Budhu A, Forgues M, Ye QH, et al. Prediction of venous raetasta-ses, recurrence, and prognosis in hepatocellular carcinoma basedon a unique immune response signature of the liver microenviron-ment[J]. Cancer Cell, 2006, 10(2) : 99-111.
  • 4Fani M, Maecke HR, Okarvi SM. Radiolabeled peptides: valuabletools for the detection and treatment of cancer [ J ]. Theranostics,2012,2(5) : 481-501.
  • 5Yang W, Luo D, Wang S,et al. TMTP1, a novel tumor-homingpeptide specifically targeting metastasis [ J ]. Clin Cancer Res,2008, 14(17) : 5494-5502.
  • 6Ametamey SM, Honer M, Schubiger PA. Molecular imaging withPET[J]. Chem Rev, 2008,108(5) : 1501-1516.
  • 7George GP, Pisaneschi F,Stevens E, et al. Scavenging strategy forspecific activity improvement : application to a new CXCR4-specific cy-clopentapeptide positron emission tomography tracer [ J ]. J LabelledComp Radiopharm, 2013,56( 13) : 679-685.
  • 8McBride WJ, Sharkey RM, Karacay H, et al. A novel method of i8Fradiolabeling for PET[J]. J Nucl Med, 2009 , 50(6) : 991-998.
  • 9Wu H, Chen H, Pan D, et al. Imaging integrin avp3 and NRP-1positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPRheterodimeric peptide probe[ J]. Mol Imaging Biol, 2014, 16(6):781-792.
  • 10Dijkgraaf I, Franssen GM, McBride WJ,et al. PET of tumors ex-pressing gastrin-releasing peptide receptor with an 18F-labeledbombesin analog[ J]. J Nucl Med, 2012,53(6) : 947-952.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部